Detalhe da pesquisa
1.
Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine.
Breast Cancer Res Treat
; 184(2): 559-565, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32808239
2.
Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine.
Breast Cancer Res Treat
; 187(2): 603, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33907908